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Background: Malaria, one of the leading causes of death in Africa, is transmitted by the bite of an infected female
Anopheles mosquito. Problems associated with the development of resistance to chemical insecticides and
concerns about the non-target effects and persistence of chemical insecticides have prompted the development of
environmentally friendly mosquito control agents. The aim of this study was to evaluate the larvicidal activity of a
genetically engineered cyanobacterium, Anabaena PCC 7120#11, against five African Anopheles species in
laboratory bioassays.
Findings: There were significant differences in the susceptibility of the anopheline species to PCC 7120#11. The
ranking of the larvicidal activity of PCC 7120#11 against species in the An. gambiae complex was: An. merus <
An. arabiensis < An. gambiae < An. quadriannulatus, where < indicates a statistically lower LC50. The LC50 of PCC
7120#11 against the important malaria vectors An. gambiae and An. arabiensis was 12.3 × 105 cells/ml and 8.10 ×
105 cells/ml, respectively. PCC 7120#11 was not effective against An. funestus, with less than 50% mortality obtained
at concentrations as high as 3.20 × 107 cells/ml.
Conclusions: PCC 7120#11 exhibited good larvicidal activity against larvae of the An. gambiae complex, but
relatively weak larvicidal activity against An. funestus. The study has highlighted the importance of evaluating a
novel mosquitocidal agent against a range of malaria vectors so as to obtain a clear understanding of the agent’s
spectrum of activity and potential as a vector control agent.
Keywords: Malaria vectors, Anopheles, Bacillus thuringiensis subsp. israelensis, Cry proteins, Cyanobacteria,
Anabaena sp. PCC 7120, Genetic engineering, Bioassays, Larvicidal activityBackground
Species within the genus Anopheles (Diptera: Culicidae)
play a major role in the transmission of malaria in Africa,
in particular mosquitoes from the An. gambiae complex
and the An. funestus group [1,2]. The An. gambiae com-
plex contains excellent and efficient vectors of malaria
(An. gambiae s.s. and An. arabiensis), as well as minor vec-
tors (An. merus) and non-vectors (An. quadriannulatus
species A and B) [1]. The An. funestus group contains an
important vector of malaria, An. funestus s.s. [2].* Correspondence: gustav.bouwer@wits.ac.za
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distribution, and reproduction in any mediumAlthough chemical insecticides have been used suc-
cessfully in integrated vector control programs [3], many
malaria vector control programs are hampered by the
development of resistance of the vectors to chemical
insecticides [4-6]. In addition to development of resist-
ance, concerns about the non-target effects and persist-
ence of the chemical insecticides have prompted the
development of environmentally friendly control agents
and control programs [7].
Bacillus thuringiensis subsp. israelensis (Bti) is a
Gram-positive, aerobic, spore-forming, bacterium that
produces crystalline inclusions that contain crystal (Cry)
or cytolytic (Cyt) proteins that are highly toxic toed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Ketseoglou and Bouwer Parasites & Vectors 2012, 5:220 Page 2 of 4
http://www.parasitesandvectors.com/content/5/1/220mosquito larvae [8,9]. Although there is low risk of re-
sistance being developed to Bti [10], there are several
disadvantages to using Bti as a control agent [11,12].
These include its low persistence in the field due to in-
activation by UV, ingestion of Bti by other aquatic
organisms, and the settling of Bti from the mosquito lar-
val feeding zone [11-13]. One strategy to overcome some
of the disadvantages of Bti is to clone the cry genes of
Bti into aquatic microorganisms that: (1) are not toxic to
other organisms, (2) inhabit and persist in the larval
feeding zone, (3) are used by mosquito larvae as a food
source, (4) express Cry proteins at levels that are mos-
quito larvicidal, and (5) have cell walls that reduce in-
activation of the Cry proteins by UV [13-15].
Xiaoqiang et al. [15] inserted the Bti cry4Aa, cry11Aa,
and p20 genes under the control of two tandem promo-
ters (cyanobacterial constitutive promoter, PpsbA, and
Escherichia coli T7 early promoter, PA1) into a filament-
ous nitrogen-fixing cyanobacterium, Anabaena sp. strain
PCC 7120 (PCC 7120). The Bti genes are integrated into
the chromosome of PCC 7120, resulting in a stable re-
combinant strain [16]. Laboratory bioassays have shown
that the resultant recombinant strain, PCC 7120#11, is a
very effective larvicidal agent against Aedes aegypti
[13,15,16].
To our knowledge, no studies have examined the larvi-
cidal activity of PCC 7120#11 against several African
malaria vectors. The aim of this study was, thus, to
evaluate the larvicidal activity of PCC 7120#11 against
five African Anopheles species in order to determine if
PCC 7120#11 may have potential as a malaria vector
control agent.
Methods
Larvicidal activity of PCC 7120#11 was determined by
laboratory bioassays against four species in the An. gam-
biae complex and one species in the An. funestus group.
The An. gambiae complex species used in the study
were (origin, colony name, and colonisation date pro-
vided): An. gambiae s.s. (Ibadan, Nigeria; NAG; 2001),
An. arabiensis (Kanyemba, Zimbabwe; KGB; 1975), An.
merus (KwaZulu-Natal, South Africa; MAF; 1988), and
An. quadriannulatus species A (Sangwe, Zimbabwe;
SANGWE; 1998). The species from the An. funestus
group that was used in the study was An. funestus s.s.
(Maputo, Mozambique; FUMOZ; 2000).
The anopheline mosquito species were obtained from
colonies maintained at the National Institute of Commu-
nicable Diseases (Johannesburg, South Africa). Since the
activity of PCC 7120#11 against A. aegypti had been pre-
viously evaluated [15], we included it as a control in the
bioassays. The A. aegypti larvae were obtained from the
South African Bureau of Standards (Pretoria, South
Africa).PCC 7120 and PCC 7120#11, were cultured in BG-11
medium [15], at 30°C under continuous illumination
(2000 lux) with constant agitation [13,16]. The PCC
7120 and PCC 7120#11 cells were harvested by differen-
tial centrifugation and the cell concentration was deter-
mined by haemocytometer counts. Two millilitres of the
appropriate dilution (covering an in-cup concentration
range of 1.00 × 104 to 3.20 × 107 cells/ml) of either PCC
7120 or PCC 7120#11 was added to 130 ml plastic cups
that contained 98 ml sterile distilled water and 20 third-
instar mosquito larvae. In the case of An. merus, a sterile
5 M saline solution was used instead of sterile distilled
water.
Larvicidal activity was determined 24 hours post-
inoculation, with larvae presumed dead if they did not
move when prodded. An untreated control (sterile dis-
tilled water) was included in the bioassays. If mortality
in the controls (PCC 7120 and untreated) exceeded
5%, the test was discarded and repeated. Each bioassay
was repeated in triplicate on different days. The lethal
concentration (LC50 and LC90) for each species was
determined by probit analysis [17]. For each species,
probit analysis was based on the mortality data
obtained from five PCC 7120#11 concentrations.
Results and discussion
The concentration-mortality data for the mosquito spe-
cies are summarised in Table 1. The heterogeneity fac-
tors for the different mosquito species evaluated were all
less than one, indicating a good fit of the concentration-
mortality data to the probit model [18].
The concentration-mortality regression slopes indicate
the variability in response to a toxin within the vector
population being examined [19]. In this study, An. ara-
biensis had a significantly steeper slope than the other
species evaluated, suggesting that An. arabiensis had
lower response variability or reduced heterogeneity in its
population compared to the other mosquito species
examined. The shallower slopes of the concentration-
mortality regression lines obtained for An. gambiae and
An. quadriannulatus mean that there are larger differ-
ences between the LC50 and LC90 values for these spe-
cies than for the other anopheline species evaluated.
Although slight variation in LC50s between studies
may be expected due to differences in experimental con-
ditions such as rearing conditions of the larvae and nat-
ural variations in the larval populations [20], the
susceptibility of A. aegypti larvae to PCC 7120#11 in this
study was comparable to that (LC50 of 0.9 × 10
5 cells/
ml) previously reported by Xiaoqiang et al. [15]. How-
ever, the LC50 value of PCC 7120#11 against A. aegypti
larvae was significantly lower than those of the anophel-
ine species evaluated (Table 1). The decreased suscepti-
bility of anopheline larvae compared to A. aegypti larvae
Table 1 Probit analysis of concentration-mortality data for Anabaena PCC 7120#11 against third instar mosquito
larvae
Species LC50 (10
5 cells/ml)* LC90 (10
5 cells/ml)* Slope ± SE† Heterogeneity{
A. aegypti 1.42 (1.12-1.76)a 8.21 (6.05-12.3)a 1.70±0.15a 0.75
An. merus 3.90 (3.58-4.17)b 9.30 (8.0-11.4)a 3.37±0.31b 0.62
An. arabiensis 8.10 (7.62-8.56)c 14.3 (12.8-16.5)b 5.18±0.46c 0.19
An. gambiae 12.3 (11.4-13.3)d 35.1 (29.5-44.9)c 2.81±0.24d 0.49
An. quadriannulatus 15.7 (14.3-17.3)e 43.0 (35.9-54.9)c 2.93±0.26bd 0.92
An. funestus N.D.} N.D. N.D. N.D.
* Values in brackets show the 95% fiducial limits (FLs). Values in a column followed by the same letters are not significantly different (overlapping 95% FLs).
† Slope ± standard error. Values followed by the same letters are not significantly different (p > 0.05).
{ Heterogeneity factor = χ2 / d.f. (degrees of freedom).
} Not determined. Less than 50% mortality was obtained even at concentrations as high as 3.2 × 107 cells/ml.
Ketseoglou and Bouwer Parasites & Vectors 2012, 5:220 Page 3 of 4
http://www.parasitesandvectors.com/content/5/1/220may be due to differences in feeding behaviour [21];
Anopheles larvae (surface feeders) may ingest fewer PCC
7120#11 cells than A. aegypti larvae that feed at all levels
in the water column.
The LC50 values differed significantly between the
anopheline species examined, with PCC 7120#11 being
most effective against An. merus larvae (Table 1). On the
basis of LC50 ratios, the larvae of An. quadriannulatus
were 4-fold less susceptible to PCC 7120#11 than the
larvae of An. merus. PCC 7120#11 had relatively weak
larvicidal activity against An. funestus, even at concen-
trations as high 3.2 × 107 cells/ml. The LC90 values for
An. merus and A. aegypti were significantly lower than
the LC90 values for An. arabiensis, An. quadriannulatus,
or An. gambiae (Table 1). Furthermore, the LC90 for An.
arabiensis was significantly lower than that of An. quad-
riannulatus or An. gambiae (Table 1).
The significant differences in susceptibility to PCC
7120#11 between the anopheline species may reflect
species-specific differences in one or more of the steps
in the ingestion-to-toxicity process. For example, differ-
ences in the ingestion rate or efficiency of digestion of
PCC 7120#11 cell walls by the different anopheline spe-
cies may significantly affect the concentration of Cry
proteins in the larval midgut. However, preliminary eva-
luations (unpublished data) did not show marked differ-
ences in the ingestion or digestion rates between An.
funestus and An. arabiensis.
A factor to consider in interpreting the significant dif-
ferences in susceptibility between An. funestus and spe-
cies of the An. gambiae complex is the combination of
the toxins present in PCC 7120#11. Bti, which naturally
produces crystals that contain the toxins Cry4Aa,
Cry4Ba, Cry10Aa, Cry11Aa, Cyt1Aa and Cyt2Ba [9,22],
has higher larvicidal activity against mosquitoes than re-
combinant clones containing a subset of toxins [9,23,24].
In a previous study [25], Bti strain HD522 was evaluated
against the same anopheline species, with An. funestus
larvae having an LC50 that was statistically similar to the
LC50 values obtained for An. arabiensis, An. gambiae,and An. merus larvae. The comparatively low larvicidal
activity of PCC 7120#11 against An. funestus could be
due to the absence of the other Bti Cry and Cyt proteins
in PCC 7120#11, which produces only the Cry4Aa and
Cry11Aa proteins. Since the larvicidal activity of Cry
proteins is often correlated with the high affinity binding
of the proteins to specific membrane-bound receptors in
the larval midgut [26,27], the susceptibility differences
could be due to inherent differences between the species
in the structure or density of midgut receptors for
Cry4Aa or Cry11Aa. In this context, it is noteworthy
that Cyt1A is known to synergize Cry11A toxicity by
functioning as a membrane-bound receptor [28]. Further
research is required to determine which combinations of
the Cry and Cyt proteins would result in the highest lar-
vicidal activity against An. funestus larvae.
PCC 7120#11 displayed good larvicidal activity against
key malaria vectors, including An. gambiae and An. ara-
biensis. Although PCC 7120#11 displayed comparatively
weak larvicidal activity against An. funestus at economic-
ally practical concentrations, PCC 7120#11 may have
potential as a larvicidal agent in geographic regions
where An. funestus is not the predominant vector. Alter-
natively, PCC 7120#11 could be applied as a larvicidal
agent as part of an integrated vector control program
that targets An. funestus adults and the larvae of other
malaria vectors. However, before PCC 7120#11 can used
in vector control programs, its effects on non-target
organisms and its persistence in aquatic environments
would have to be comprehensively evaluated.
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